NRT Smoking Cessation Aids in Guatemala

May 2013 | 17 pages | ID: N1059C9C575EN
Euromonitor International Ltd

Abstracts

NRT smoking cessation aids posted 13% current value growth in 2012 and reached sales of GTQ2.6 million. Smoking has been prohibited in public places in Guatemala since 2009, when the Government approved the smoking ban. Although the law is not strictly reinforced, there is greater awareness of the potential health implications of smoking and smoking in public places such as restaurants has diminished. Nevertheless, in 2012 it was estimated that there were 1.7 million smokers in Guatemala, which...

Euromonitor International's NRT Smoking Cessation Aids in Guatemala report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the NRT Smoking Cessation Aids market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning."

Contents

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Number of Smokers by Gender 2007-2012
Category Data
  Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2007-2012
  Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2007-2012
  Table 4 NRT Smoking Cessation Aids Company Shares 2008-2012
  Table 5 NRT Smoking Cessation Aids Brand Shares 2009-2012
  Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
  Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
Executive Summary
Strong Growth Achieved in 2012
Contraband and Counterfeit Products Have A Negative Impact on Consumer Health Sales
International Companies Lead Sales in Consumer Health
Chemists/pharmacies the Most Important Retail Channel
Strong Forecast Performance Expected
Key Trends and Developments
Urbanisation, A Key Driver of OTC Demand in Guatemala
International Brands Lead Consumer Health in Guatemala
Generic Brands Continue To Grow in Guatemala
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 9 Life Expectancy at Birth 2007-2012
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2007-2012
  Table 11 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 12 Consumer Health Company Shares 2008-2012
  Table 13 Consumer Health Brand Shares 2009-2012
  Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 16 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Sources
Summary 1 Research Sources